✦ LIBER ✦

Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer

✍ Scribed by Hendricksen, K.; Cornel, E.B.; de Reijke, T.M.; Arentsen, H.C.; Chawla, S.; Witjes, J.A.

Book ID: 118484270
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 195 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.11.101

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Marker Lesion Study With Intrav

Phase II Marker Lesion Study With Intravesical Instillation of Apaziquone for Superficial Bladder Cancer: Toxicity and Marker Response

✍ van der Heijden, Antoine G.; Moonen, Paula M.J.; Cornel, Erik B.; Vergunst, Henk 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 80 KB

Phase I/II Pilot Study of Intravesical A

Phase I/II Pilot Study of Intravesical Apaziquone (EO9) for Superficial Bladder Cancer

✍ Puri, Rajiv; Palit, Victor; Loadman, Paul M.; Flannigan, Michael; Shah, Tariq; C 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 318 KB

Two-year follow-up of the phase II marke

Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer

✍ Kees Hendricksen; Antoine G. van der Heijden; Erik B. Cornel; Henk Vergunst; The 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 286 KB

Results of a Phase 1 Dose Escalation Stu

Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer

✍ Falke, Johannes; Lammers, Rianne J.M.; Arentsen, Harm C.; Ravic, Miroslav; Pozzi 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 430 KB

C34 THE ROLE OF ADJUVANT INTRAVESICAL BC

C34 THE ROLE OF ADJUVANT INTRAVESICAL BCG THERAPY FOR MEDIUM/HIGH RISK NON-INVASIVE BLADDER TUMOURS

✍ Gluck, G.; Chirita, M.M.; Stoica, R.; Daia, D.; Sinescu, I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Prognostic Value of p53 and Ki-67 Expres

Prognostic Value of p53 and Ki-67 Expression in Intermediate-risk Patients With Nonmuscle-invasive Bladder Cancer Receiving Adjuvant Intravesical Mitomycin C Therapy

✍ Ho Kyung Seo; Kang Su Cho; Jinsoo Chung; Jae Young Joung; Weon Seo Park; Moon Ke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 323 KB